SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

GB Sciences Inc. – ‘10-Q’ for 12/31/20 – ‘XML’

On:  Tuesday, 2/16/21, at 2:16pm ET   ·   For:  12/31/20   ·   Accession #:  1437749-21-2961   ·   File #:  0-55462

Previous ‘10-Q’:  ‘10-Q’ on 11/13/20 for 9/30/20   ·   Next:  ‘10-Q’ on 8/13/21 for 6/30/21   ·   Latest:  ‘10-Q’ on 2/12/24 for 12/31/23   ·   6 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/16/21  GB Sciences Inc.                  10-Q       12/31/20   54:8.3M                                   RDG Filings/FA

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    761K 
 2: EX-10.1     Exhibit 10.1 Judgment Settlement Agreement          HTML     49K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     19K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     19K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     17K 
 6: EX-32.2     Certification -- §906 - SOA'02                      HTML     17K 
13: R1          Document And Entity Information                     HTML     45K 
14: R2          Condensed Consolidated Balance Sheets (Current      HTML    107K 
                Period Unaudited)                                                
15: R3          Condensed Consolidated Balance Sheets (Current      HTML     30K 
                Period Unaudited) (Parentheticals)                               
16: R4          Condensed Consolidated Statements of Operations     HTML    155K 
                (Unaudited)                                                      
17: R5          Condensed Consolidated Statements of Cash Flows     HTML    178K 
                (Unaudited)                                                      
18: R6          Condensed Consolidated Statements of Changes in     HTML    112K 
                Stockholders' Equity/(Deficit) (Unaudited)                       
19: R7          Note 1 - Background and Significant Accounting      HTML     83K 
                Policies                                                         
20: R8          Note 2 - Going Concern                              HTML     24K 
21: R9          Note 3 - Discontinued Operations                    HTML    396K 
22: R10         Note 4 - Leases (Continuing Operations)             HTML     21K 
23: R11         Note 5 - Notes Payable and Line of Credit           HTML     62K 
24: R12         Note 6 - Convertible Notes                          HTML     56K 
25: R13         Note 7 - Capital Transactions                       HTML     29K 
26: R14         Note 8 - Commitments and Contingencies              HTML     27K 
27: R15         Note 9 - Related Party Transactions                 HTML     22K 
28: R16         Note 10 - Sale of Membership Interests in GB        HTML     28K 
                Sciences Louisiana, LLC                                          
29: R17         Note 11 - Sale of Membership Interests in Nevada    HTML     33K 
                Subsidiaries                                                     
30: R18         Note 12 - Subsequent Events                         HTML     21K 
31: R19         Significant Accounting Policies (Policies)          HTML    124K 
32: R20         Note 1 - Background and Significant Accounting      HTML     54K 
                Policies (Tables)                                                
33: R21         Note 3 - Discontinued Operations (Tables)           HTML    391K 
34: R22         Note 5 - Notes Payable and Line of Credit (Tables)  HTML     43K 
35: R23         Note 1 - Background and Significant Accounting      HTML     20K 
                Policies (Details Textual)                                       
36: R24         Note 1 - Background and Significant Accounting      HTML     59K 
                Policies - Earnings (Loss) Per Share (Details)                   
37: R25         Note 2 - Going Concern (Details Textual)            HTML     27K 
38: R26         Note 3 - Discontinued Operations (Details Textual)  HTML     46K 
39: R27         Note 3 - Discontinued Operations - Discontinued     HTML    256K 
                Operations (Details)                                             
40: R28         Note 3 - Discontinued Operations - Schedule of      HTML     29K 
                Inventory (Details)                                              
41: R29         Note 3 - Discontinued Operations - Future Minimum   HTML     40K 
                Lease Payments (Details)                                         
42: R30         Note 4 - Leases (Continuing Operations) (Details    HTML     27K 
                Textual)                                                         
43: R31         Note 5 - Notes Payable and Line of Credit (Details  HTML    155K 
                Textual)                                                         
44: R32         Note 5 - Notes Payable and Line of Credit -         HTML     70K 
                Schedule of Debt Payable (Details)                               
45: R33         Note 6 - Convertible Notes (Details Textual)        HTML    295K 
46: R34         Note 7 - Capital Transactions (Details Textual)     HTML    109K 
47: R35         Note 8 - Commitments and Contingencies (Details     HTML     46K 
                Textual)                                                         
48: R36         Note 9 - Related Party Transactions (Details        HTML     31K 
                Textual)                                                         
49: R37         Note 10 - Sale of Membership Interests in GB        HTML     65K 
                Sciences Louisiana, LLC (Details Textual)                        
50: R38         Note 11 - Sale of Membership Interests in Nevada    HTML     98K 
                Subsidiaries (Details Textual)                                   
51: R39         Note 12 - Subsequent Events (Details Textual)       HTML     35K 
53: XML         IDEA XML File -- Filing Summary                      XML     93K 
52: EXCEL       IDEA Workbook of Financial Reports                  XLSX     76K 
 7: EX-101.INS  XBRL Instance -- gblx-20201231                       XML   2.59M 
 9: EX-101.CAL  XBRL Calculations -- gblx-20201231_cal               XML    196K 
10: EX-101.DEF  XBRL Definitions -- gblx-20201231_def                XML   1.39M 
11: EX-101.LAB  XBRL Labels -- gblx-20201231_lab                     XML   1.14M 
12: EX-101.PRE  XBRL Presentations -- gblx-20201231_pre              XML   1.39M 
 8: EX-101.SCH  XBRL Schema -- gblx-20201231                         XSD    184K 
54: ZIP         XBRL Zipped Folder -- 0001437749-21-002961-xbrl      Zip    193K

‘XML’   —   IDEA XML File — Filing Summary

This Document is an IDEA XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.20.4 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 289 </ContextCount>
<ElementCount> 449 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> false </FootnotesReported>
<SegmentCount> 86 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 4 </UnitCount>
<MyReports>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 000 - Document - Document And Entity Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-document-and-entity-information </Role>
<ShortName> Document And Entity Information </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited </Role>
<ShortName> Condensed Consolidated Balance Sheets (Current Period Unaudited) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 2 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals </Role>
<ShortName> Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 3 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-condensed-consolidated-statements-of-operations-unaudited </Role>
<ShortName> Condensed Consolidated Statements of Operations (Unaudited) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 4 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 004 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited </Role>
<ShortName> Condensed Consolidated Statements of Cash Flows (Unaudited) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 5 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity/(Deficit) (Unaudited) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-condensed-consolidated-statements-of-changes-in-stockholders-equitydeficit-unaudited </Role>
<ShortName> Condensed Consolidated Statements of Changes in Stockholders' Equity/(Deficit) (Unaudited) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 6 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 006 - Disclosure - Note 1 - Background and Significant Accounting Policies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-1-background-and-significant-accounting-policies </Role>
<ShortName> Note 1 - Background and Significant Accounting Policies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 7 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 007 - Disclosure - Note 2 - Going Concern </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-2-going-concern </Role>
<ShortName> Note 2 - Going Concern </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 8 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 008 - Disclosure - Note 3 - Discontinued Operations </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-3-discontinued-operations </Role>
<ShortName> Note 3 - Discontinued Operations </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 9 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 009 - Disclosure - Note 4 - Leases (Continuing Operations) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-4-leases-continuing-operations </Role>
<ShortName> Note 4 - Leases (Continuing Operations) </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 10 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 010 - Disclosure - Note 5 - Notes Payable and Line of Credit </LongName>
<ReportType> Notes </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-5-notes-payable-and-line-of-credit </Role>
<ShortName> Note 5 - Notes Payable and Line of Credit </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 11 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 011 - Disclosure - Note 6 - Convertible Notes </LongName>
<ReportType> Notes </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-6-convertible-notes </Role>
<ShortName> Note 6 - Convertible Notes </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 12 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 012 - Disclosure - Note 7 - Capital Transactions </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-7-capital-transactions </Role>
<ShortName> Note 7 - Capital Transactions </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 13 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 013 - Disclosure - Note 8 - Commitments and Contingencies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-8-commitments-and-contingencies </Role>
<ShortName> Note 8 - Commitments and Contingencies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 14 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 014 - Disclosure - Note 9 - Related Party Transactions </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-9-related-party-transactions </Role>
<ShortName> Note 9 - Related Party Transactions </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 15 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 015 - Disclosure - Note 10 - Sale of Membership Interests in GB Sciences Louisiana, LLC </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-10-sale-of-membership-interests-in-gb-sciences-louisiana-llc </Role>
<ShortName> Note 10 - Sale of Membership Interests in GB Sciences Louisiana, LLC </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 16 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 016 - Disclosure - Note 11 - Sale of Membership Interests in Nevada Subsidiaries </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-11-sale-of-membership-interests-in-nevada-subsidiaries </Role>
<ShortName> Note 11 - Sale of Membership Interests in Nevada Subsidiaries </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 17 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 017 - Disclosure - Note 12 - Subsequent Events </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-12-subsequent-events </Role>
<ShortName> Note 12 - Subsequent Events </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 18 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 018 - Disclosure - Significant Accounting Policies (Policies) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-significant-accounting-policies-policies </Role>
<ShortName> Significant Accounting Policies (Policies) </ShortName>
<MenuCategory> Policies </MenuCategory>
<ParentRole> http://gbsciences.com/20201231/role/statement-note-1-background-and-significant-accounting-policies </ParentRole>
<Position> 19 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 019 - Disclosure - Note 1 - Background and Significant Accounting Policies (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-1-background-and-significant-accounting-policies-tables </Role>
<ShortName> Note 1 - Background and Significant Accounting Policies (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://gbsciences.com/20201231/role/statement-note-1-background-and-significant-accounting-policies </ParentRole>
<Position> 20 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 020 - Disclosure - Note 3 - Discontinued Operations (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-3-discontinued-operations-tables </Role>
<ShortName> Note 3 - Discontinued Operations (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://gbsciences.com/20201231/role/statement-note-3-discontinued-operations </ParentRole>
<Position> 21 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 021 - Disclosure - Note 5 - Notes Payable and Line of Credit (Tables) </LongName>
<ReportType> Notes </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-5-notes-payable-and-line-of-credit-tables </Role>
<ShortName> Note 5 - Notes Payable and Line of Credit (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://gbsciences.com/20201231/role/statement-note-5-notes-payable-and-line-of-credit </ParentRole>
<Position> 22 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 022 - Disclosure - Note 1 - Background and Significant Accounting Policies (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-1-background-and-significant-accounting-policies-details-textual </Role>
<ShortName> Note 1 - Background and Significant Accounting Policies (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://gbsciences.com/20201231/role/statement-note-1-background-and-significant-accounting-policies-tables </ParentRole>
<Position> 23 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 023 - Disclosure - Note 1 - Background and Significant Accounting Policies - Earnings (Loss) Per Share (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-1-background-and-significant-accounting-policies-earnings-loss-per-share-details </Role>
<ShortName> Note 1 - Background and Significant Accounting Policies - Earnings (Loss) Per Share (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://gbsciences.com/20201231/role/statement-note-1-background-and-significant-accounting-policies-tables </ParentRole>
<Position> 24 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 024 - Disclosure - Note 2 - Going Concern (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-2-going-concern-details-textual </Role>
<ShortName> Note 2 - Going Concern (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://gbsciences.com/20201231/role/statement-note-2-going-concern </ParentRole>
<Position> 25 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R26.htm </HtmlFileName>
<LongName> 025 - Disclosure - Note 3 - Discontinued Operations (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-3-discontinued-operations-details-textual </Role>
<ShortName> Note 3 - Discontinued Operations (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://gbsciences.com/20201231/role/statement-note-3-discontinued-operations-tables </ParentRole>
<Position> 26 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R27.htm </HtmlFileName>
<LongName> 026 - Disclosure - Note 3 - Discontinued Operations - Discontinued Operations (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-3-discontinued-operations-discontinued-operations-details </Role>
<ShortName> Note 3 - Discontinued Operations - Discontinued Operations (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 27 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R28.htm </HtmlFileName>
<LongName> 027 - Disclosure - Note 3 - Discontinued Operations - Schedule of Inventory (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-3-discontinued-operations-schedule-of-inventory-details </Role>
<ShortName> Note 3 - Discontinued Operations - Schedule of Inventory (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 28 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R29.htm </HtmlFileName>
<LongName> 028 - Disclosure - Note 3 - Discontinued Operations - Future Minimum Lease Payments (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-3-discontinued-operations-future-minimum-lease-payments-details </Role>
<ShortName> Note 3 - Discontinued Operations - Future Minimum Lease Payments (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 29 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R30.htm </HtmlFileName>
<LongName> 029 - Disclosure - Note 4 - Leases (Continuing Operations) (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-4-leases-continuing-operations-details-textual </Role>
<ShortName> Note 4 - Leases (Continuing Operations) (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://gbsciences.com/20201231/role/statement-note-4-leases-continuing-operations </ParentRole>
<Position> 30 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R31.htm </HtmlFileName>
<LongName> 030 - Disclosure - Note 5 - Notes Payable and Line of Credit (Details Textual) </LongName>
<ReportType> Notes </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-5-notes-payable-and-line-of-credit-details-textual </Role>
<ShortName> Note 5 - Notes Payable and Line of Credit (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://gbsciences.com/20201231/role/statement-note-5-notes-payable-and-line-of-credit-tables </ParentRole>
<Position> 31 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R32.htm </HtmlFileName>
<LongName> 031 - Disclosure - Note 5 - Notes Payable and Line of Credit - Schedule of Debt Payable (Details) </LongName>
<ReportType> Notes </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-5-notes-payable-and-line-of-credit-schedule-of-debt-payable-details </Role>
<ShortName> Note 5 - Notes Payable and Line of Credit - Schedule of Debt Payable (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 32 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R33.htm </HtmlFileName>
<LongName> 032 - Disclosure - Note 6 - Convertible Notes (Details Textual) </LongName>
<ReportType> Notes </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-6-convertible-notes-details-textual </Role>
<ShortName> Note 6 - Convertible Notes (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://gbsciences.com/20201231/role/statement-note-6-convertible-notes </ParentRole>
<Position> 33 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R34.htm </HtmlFileName>
<LongName> 033 - Disclosure - Note 7 - Capital Transactions (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-7-capital-transactions-details-textual </Role>
<ShortName> Note 7 - Capital Transactions (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://gbsciences.com/20201231/role/statement-note-7-capital-transactions </ParentRole>
<Position> 34 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R35.htm </HtmlFileName>
<LongName> 034 - Disclosure - Note 8 - Commitments and Contingencies (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-8-commitments-and-contingencies-details-textual </Role>
<ShortName> Note 8 - Commitments and Contingencies (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://gbsciences.com/20201231/role/statement-note-8-commitments-and-contingencies </ParentRole>
<Position> 35 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R36.htm </HtmlFileName>
<LongName> 035 - Disclosure - Note 9 - Related Party Transactions (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-9-related-party-transactions-details-textual </Role>
<ShortName> Note 9 - Related Party Transactions (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://gbsciences.com/20201231/role/statement-note-9-related-party-transactions </ParentRole>
<Position> 36 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R37.htm </HtmlFileName>
<LongName> 036 - Disclosure - Note 10 - Sale of Membership Interests in GB Sciences Louisiana, LLC (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-10-sale-of-membership-interests-in-gb-sciences-louisiana-llc-details-textual </Role>
<ShortName> Note 10 - Sale of Membership Interests in GB Sciences Louisiana, LLC (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://gbsciences.com/20201231/role/statement-note-10-sale-of-membership-interests-in-gb-sciences-louisiana-llc </ParentRole>
<Position> 37 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R38.htm </HtmlFileName>
<LongName> 037 - Disclosure - Note 11 - Sale of Membership Interests in Nevada Subsidiaries (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-11-sale-of-membership-interests-in-nevada-subsidiaries-details-textual </Role>
<ShortName> Note 11 - Sale of Membership Interests in Nevada Subsidiaries (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://gbsciences.com/20201231/role/statement-note-11-sale-of-membership-interests-in-nevada-subsidiaries </ParentRole>
<Position> 38 </Position>
</Report>
<Report instance="gblx-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R39.htm </HtmlFileName>
<LongName> 038 - Disclosure - Note 12 - Subsequent Events (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://gbsciences.com/20201231/role/statement-note-12-subsequent-events-details-textual </Role>
<ShortName> Note 12 - Subsequent Events (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://gbsciences.com/20201231/role/statement-note-12-subsequent-events </ParentRole>
<Position> 39 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<InputFiles>
<File> gblx-20201231.xml </File>
<File> gblx-20201231.xsd </File>
<File> gblx-20201231_cal.xml </File>
<File> gblx-20201231_def.xml </File>
<File> gblx-20201231_lab.xml </File>
<File> gblx-20201231_pre.xml </File>
</InputFiles>
<SupplementalFiles/>
<BaseTaxonomies>
<BaseTaxonomy> http://fasb.org/us-gaap/2020-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://xbrl.sec.gov/dei/2019-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://fasb.org/srt/2020-01-31 </BaseTaxonomy>
</BaseTaxonomies>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/21/21  GB Sciences Inc.                  424B3                  1:3.5M                                   RDG Filings/FA
 9/17/21  GB Sciences Inc.                  S-1                  104:17M                                    RDG Filings/FA
 7/06/21  GB Sciences Inc.                  10-K        3/31/21   92:11M                                    RDG Filings/FA

3 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/28/20  GB Sciences Inc.                  10-K        3/31/20   96:12M                                    RDG Filings/FA
 6/27/14  GB Sciences Inc.                  10-K        3/31/14   11:1.2M                                   Henrie Gary R/FA
 2/12/02  GB Sciences Inc.                  SB-2                   1:166K                                   Elec Delivery Sy… Inc/FA
↑Top
Filing Submission 0001437749-21-002961   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Thu., May 2, 12:40:43.1pm ET